Companion Animals

Dog Atopic Dermatitis: Immunotherapy and Biologics Advances

Canine atopic dermatitis causes chronic itching and secondary infection, with significant advances in treatment improving welfare outcomes.

Key Facts

Atopy affects 10-15% of dogs and significantly reduces quality of life
Allergen-specific immunotherapy achieves partial or full remission in 50-80% of treated dogs
Oclacitinib (Apoquel) and lokivetmab (Cytopoint) provide fast itch relief
Finding and managing environmental triggers reduces medication burden long-term

Welfare Considerations

Chronic itch causes continuous discomfort and self-trauma from scratching and chewing. Modern targeted therapies dramatically reduce the itch-scratch cycle with fewer side effects than older corticosteroid treatments. Early specialist referral improves long-term outcomes.

What You Can Do

Seek referral to a veterinary dermatologist for dogs with chronic skin disease
Discuss allergen immunotherapy as a long-term management option
Manage environmental triggers including house dust mite to reduce allergen load